Skip to main content
Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.613
-0.032 (-4.93%)
At close: Apr 28, 2026, 4:00 PM EDT
0.613
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:30 AM EDT

Trinity Biotech Revenue

Trinity Biotech had revenue of $14.31M in the quarter ending September 30, 2025, a decrease of -5.54%. This brings the company's revenue in the last twelve months to $48.57M, down -17.85% year-over-year. In the year 2024, Trinity Biotech had annual revenue of $61.56M with 8.31% growth.

Revenue (ttm)
$48.57M
Revenue Growth
-17.85%
P/S Ratio
0.24
Revenue / Employee
$121,122
Employees
401
Market Cap
11.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202461.56M4.72M8.31%
Dec 31, 202356.83M-5.69M-9.10%
Dec 31, 202262.52M-18.63M-22.96%
Dec 31, 202181.15M-20.83M-20.43%
Dec 31, 2020101.98M11.55M12.77%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IRIDEX 52.68M
Vivos Therapeutics 17.44M
Biomerica 4.33M
Tenon Medical 3.94M
VolitionRx 1.73M
Sintx Technologies 1.02M
iTonic Holdings 523.03K
Nexalin Technology 301.65K
Revenue Rankings

TRIB News

More News